Gilead Sciences, Inc. (GILD)
156.04
-1.15
(-0.73%)
USD |
NASDAQ |
Oct 23, 16:00
156.41
+0.37
(+0.24%)
After-Hours: 20:00
Gilead Sciences Price : 156.04 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 156.47 | 157.65 | 155.76 | 156.04 | 6.071M |
| Oct 22, 2026 | 154.24 | 157.42 | 153.00 | 157.19 | 6.211M |
| Oct 21, 2026 | 154.73 | 155.42 | 151.71 | 153.57 | 6.221M |
| Oct 20, 2026 | 155.37 | 157.48 | 154.02 | 156.51 | 5.793M |
| Oct 19, 2026 | 155.38 | 157.24 | 152.92 | 153.07 | 6.835M |
| Oct 16, 2026 | 157.32 | 157.58 | 155.62 | 156.19 | 7.772M |
| Oct 15, 2026 | 156.39 | 160.51 | 156.02 | 157.37 | 8.288M |
| Oct 14, 2026 | 148.19 | 153.76 | 147.48 | 153.54 | 5.761M |
| Oct 13, 2026 | 151.16 | 151.16 | 147.26 | 147.92 | 5.558M |
| Oct 12, 2026 | 151.84 | 152.26 | 149.80 | 150.43 | 5.792M |
| Oct 09, 2026 | 147.23 | 151.44 | 146.10 | 151.17 | 5.802M |
| Oct 08, 2026 | 146.73 | 147.59 | 144.65 | 147.10 | 4.490M |
| Oct 07, 2026 | 145.28 | 148.60 | 144.85 | 146.85 | 5.097M |
| Oct 06, 2026 | 145.11 | 146.14 | 142.60 | 144.23 | 3.724M |
| Oct 05, 2026 | 143.21 | 145.16 | 142.79 | 144.63 | 6.138M |
| Oct 02, 2026 | 147.65 | 148.00 | 144.00 | 144.74 | 5.044M |
| Oct 01, 2026 | 149.44 | 149.44 | 147.18 | 147.50 | 4.439M |
| Sep 30, 2026 | 150.88 | 151.28 | 148.98 | 149.05 | 5.357M |
| Sep 29, 2026 | 150.18 | 152.62 | 148.78 | 151.28 | 5.323M |
| Sep 28, 2026 | 149.80 | 152.74 | 149.41 | 152.21 | 5.082M |
| Sep 25, 2026 | 150.05 | 151.00 | 148.02 | 150.93 | 5.284M |
| Sep 24, 2026 | 151.10 | 152.98 | 149.59 | 149.69 | 5.075M |
| Sep 23, 2026 | 153.60 | 154.20 | 150.06 | 151.37 | 6.192M |
| Sep 22, 2026 | 150.64 | 153.28 | 148.65 | 152.67 | 5.083M |
| Sep 21, 2026 | 150.11 | 152.10 | 148.22 | 150.56 | 5.569M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 285.64 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
| Amgen, Inc. | 439.26 |
| Biogen, Inc. | 250.69 |
| Johnson & Johnson | 263.81 |
Price Related Metrics
| PS Ratio | 6.391 |
| Price to Book Value | 16.37 |
| Price to Free Cash Flow | 15.08 |
| Earnings Yield | -1.70% |
| Market Cap | 193.65B |
| Operating PE Ratio | 16.37 |
| Normalized PE Ratio | 32.84 |